Next Article in Journal
Poly(ADP-Ribose) Polymerase Inhibitors in Pancreatic Cancer: A New Treatment Paradigms and Future Implications
Next Article in Special Issue
The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response
Previous Article in Journal
Engineered Extracellular Vesicles as a Reliable Tool in Cancer Nanomedicine
Previous Article in Special Issue
Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?
 
 
Article

Article Versions Notes

Cancers 2019, 11(12), 1981; https://doi.org/10.3390/cancers11121981
Action Date Notes Link
article xml file uploaded 9 December 2019 12:52 CET Original file -
article xml uploaded. 9 December 2019 12:52 CET Update https://www.mdpi.com/2072-6694/11/12/1981/xml
article pdf uploaded. 9 December 2019 12:52 CET Version of Record https://www.mdpi.com/2072-6694/11/12/1981/pdf
article supplementary file uploaded. 9 December 2019 12:52 CET - https://www.mdpi.com/2072-6694/11/12/1981#supplementary
article html file updated 9 December 2019 12:53 CET Original file -
article html file updated 30 December 2019 15:10 CET Update -
article html file updated 14 February 2020 17:09 CET Update -
article html file updated 19 July 2022 22:08 CEST Update https://www.mdpi.com/2072-6694/11/12/1981/html
Back to TopTop